KR20060122872A - 피셔-핑크형 합성 및 후속 아실화에 의한4,5-디알킬-3-아실-피롤-2-카복실산 유도체의 제조 - Google Patents

피셔-핑크형 합성 및 후속 아실화에 의한4,5-디알킬-3-아실-피롤-2-카복실산 유도체의 제조 Download PDF

Info

Publication number
KR20060122872A
KR20060122872A KR1020067010241A KR20067010241A KR20060122872A KR 20060122872 A KR20060122872 A KR 20060122872A KR 1020067010241 A KR1020067010241 A KR 1020067010241A KR 20067010241 A KR20067010241 A KR 20067010241A KR 20060122872 A KR20060122872 A KR 20060122872A
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
aliphatic
alicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020067010241A
Other languages
English (en)
Korean (ko)
Inventor
마이클 월레스
Original Assignee
버텍스 파마슈티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 버텍스 파마슈티칼스 인코포레이티드 filed Critical 버텍스 파마슈티칼스 인코포레이티드
Publication of KR20060122872A publication Critical patent/KR20060122872A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020067010241A 2003-10-28 2004-10-28 피셔-핑크형 합성 및 후속 아실화에 의한4,5-디알킬-3-아실-피롤-2-카복실산 유도체의 제조 Abandoned KR20060122872A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51528303P 2003-10-28 2003-10-28
US60/515,283 2003-10-28

Publications (1)

Publication Number Publication Date
KR20060122872A true KR20060122872A (ko) 2006-11-30

Family

ID=34549387

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067010241A Abandoned KR20060122872A (ko) 2003-10-28 2004-10-28 피셔-핑크형 합성 및 후속 아실화에 의한4,5-디알킬-3-아실-피롤-2-카복실산 유도체의 제조

Country Status (11)

Country Link
US (2) US7250520B2 (enExample)
EP (1) EP1678134B1 (enExample)
JP (2) JP4942485B2 (enExample)
KR (1) KR20060122872A (enExample)
CN (1) CN1894211A (enExample)
AT (1) ATE442355T1 (enExample)
AU (1) AU2004285972A1 (enExample)
DE (1) DE602004023105D1 (enExample)
ES (1) ES2330944T3 (enExample)
IL (1) IL175253A0 (enExample)
WO (1) WO2005042484A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79749C2 (en) 1996-10-18 2007-07-25 Vertex Pharma Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
TWI359147B (en) 2003-09-05 2012-03-01 Vertex Pharma Inhibitors of serine proteases, particularly hcv n
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AU2007217355B2 (en) 2006-02-27 2012-06-21 Vertex Pharmaceuticals Incorporated Co-crystals comprising VX-950 and pharmaceutical compositions comprising the same
EP2194039A1 (en) 2006-03-16 2010-06-09 Vertex Pharmceuticals Incorporated Process for preparing optically enriched compounds
CA2679312A1 (en) 2007-02-27 2008-09-04 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
CN101903392A (zh) 2007-02-27 2010-12-01 弗特克斯药品有限公司 丝氨酸蛋白酶的抑制剂
WO2009032198A1 (en) 2007-08-30 2009-03-12 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
EP2489346A1 (en) 2011-01-26 2012-08-22 NanotecMARIN GmbH Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
JP2015053226A (ja) 2013-09-09 2015-03-19 タイコエレクトロニクスジャパン合同会社 電気コネクタの端子、及び電気コネクタ
US10207974B1 (en) 2017-12-05 2019-02-19 Chevron Phillips Chemical Company Lp Synthesis of gamma dicarbonyl and pyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481369C (en) 2002-04-11 2012-07-10 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
TW200510391A (en) * 2003-04-11 2005-03-16 Vertex Pharma Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Also Published As

Publication number Publication date
JP4942485B2 (ja) 2012-05-30
US7250520B2 (en) 2007-07-31
AU2004285972A1 (en) 2005-05-12
DE602004023105D1 (de) 2009-10-22
ES2330944T3 (es) 2009-12-17
JP2007509991A (ja) 2007-04-19
CN1894211A (zh) 2007-01-10
HK1092134A1 (en) 2007-02-02
WO2005042484A1 (en) 2005-05-12
US20050143585A1 (en) 2005-06-30
IL175253A0 (en) 2006-09-05
EP1678134A1 (en) 2006-07-12
EP1678134B1 (en) 2009-09-09
US20080167480A1 (en) 2008-07-10
JP2011231117A (ja) 2011-11-17
ATE442355T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
US20080167480A1 (en) Processes for preparing pyrroles
US7399758B2 (en) Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US6841566B2 (en) Viral polymerase inhibitors
EP1414797B9 (en) Hepatitis c virus polymerase inhibitors with a heterobicylic structure
US7838537B2 (en) Viral polymerase inhibitors
CA2445938C (en) Hepatitis c inhibitor tri-peptides
US7705146B2 (en) Hepatitis C inhibitor peptide analogs
JP6506836B2 (ja) Ｂ型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン
JP4939527B2 (ja) 抗ウィルス剤の機能を有する両複素環連結化合物、その応用および当該化合物を含有する組成物
WO2007001406A2 (en) Aryl-containing macrocyclic compounds
US20080200497A1 (en) Hepatitis C Inhibitor Peptide Analogs
CA2369970A1 (en) Hepatitis c inhibitor tri-peptides
AU2005263135A1 (en) Viral polymerase inhibitors
EP1440068A1 (en) Acyl dihydro pyrrole derivatives as hcv inhibitors
WO2004096210A1 (en) Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
WO2008017688A1 (en) 2-carboxy thiophene derivatives as anti-viral agents
WO2008125599A1 (en) 2-carboxy thiophene derivatives as anti-viral agents
Vendeville et al. Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors
HK1092134B (en) Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation
CN109456375B (zh) 一种抑制丙肝病毒的含单糖基杂环类化合物及制备方法
US20050171349A1 (en) Method for producing n-ethyl-n-{3-(3-cyanopyrazolo{1,5a}pyrimidine-7-yl)phenyl acetamide
AU2011265547A1 (en) Preparation of 4,5-Dialkyl-3-Acyl-Pyrrole-2-Carboxylic Acid Derivatives by Fischer-Fink Type Synthesis and Subsequent Acylation
CN111100133B (zh) 一种金属卟啉化合物及其制法和应用
CN104926712B (zh) 合成特拉匹韦的中间体及其制备方法
Chen et al. Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060525

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20091028

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110513

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20120201

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee